{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T01:49:08Z","timestamp":1702432148918},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,6,29]],"date-time":"2006-06-29T00:00:00Z","timestamp":1151539200000},"content-version":"vor","delay-in-days":8914,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Scand J Immunol"],"published-print":{"date-parts":[[1982,2]]},"abstract":"<jats:p>A male infant with partial DiGeorge syndrome responded to weekly administration of levamisole (2.5 mg\/kg of body weight) with an increase of circulating E\u2010rosette\u2010forming T cells. Thymic hormone activity in plasma appeared to be elevated to a near\u2010normal level of 11.6 ng thymopoietin equivalent\/ml after levamisole administration. The in vitro incubation studies indicated that levamisole by itself had no E\u2010rosette\u2010promoting ability, but a dialysable and relatively heat\u2010stable plasma factor induced by levamisole both in the patient and in heallhy individuals had E\u2010rosette\u2010promoting activity for the patient's lymphocytes. Such a plasma factor, however, could not be induced in all four thymectomized myasthenic subjects examined, suggesting a thymus\u2010dependent nature of the plasma factor. These results suggest that levamisole might mediate an increased secretion of humoral factor(s) with E\u2010rosette\u2010promoting activity, even from such a rudimentary thymus as in the partial DiGeorge syndrome.<\/jats:p>","DOI":"10.1111\/j.1365-3083.1982.tb00632.x","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T17:04:44Z","timestamp":1151687084000},"page":"141-148","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Induction of E\u2010Rosette\u2010Promoting Factor in Human Plasma by Levamisole: An Assessment in a Patient with Partial DiGeorge Syndrome"],"prefix":"10.1111","volume":"15","author":[{"given":"H.","family":"SEKI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"YOKOI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"KUBO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"MORIYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"MIYAWAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"NAGAOKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"MIURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"TANIGUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,29]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-197907000-00001"},{"key":"e_1_2_1_3_2","first-page":"331","volume-title":"Immunodeficiency","author":"Aiuti F.","year":"1978"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80132-6"},{"key":"e_1_2_1_5_2","first-page":"342","article-title":"Hypogammaglobulinemia during levamisole treatment: case report","volume":"41","author":"Berghs H.","year":"1978","journal-title":"Ann. Allergy"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(79)80207-3"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(65)81796-6"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.7.1800"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1975.tb29067.x"},{"issue":"4","key":"e_1_2_1_10_2","first-page":"143","article-title":"Mode of action of levamisole","volume":"5","author":"Goldstein G.","year":"1978","journal-title":"J. Rheumatol."},{"key":"e_1_2_1_11_2","first-page":"235","article-title":"Pharmacokinetic studies on levamisole: on the pharmacokinetics and relative bioavailability of levamisole in man","volume":"2","author":"Graziani G.","year":"1977","journal-title":"Drugs exp. clin."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91601-4"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(69)90647-3"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1979.tb01387.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1978.tb00510.x"},{"key":"e_1_2_1_16_2","first-page":"316","article-title":"Partial DiGeorge syndrome with substantial cell\u2010mediated immunity","volume":"130","author":"Pabst F.H.","year":"1976","journal-title":"Am. J. Dis. Child."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.145.2.466"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197210192871602"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00201973"},{"key":"e_1_2_1_20_2","first-page":"39","article-title":"Immunodeficiency diseases. I. T\u2010lymphocyte precursors and T\u2010lymphocyte differentiation in partial DiGeorge syndrome","volume":"21","author":"Touraine J.L.","year":"1975","journal-title":"Clin. exp. lmmunol."},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)91175-6"},{"key":"e_1_2_1_22_2","first-page":"65","article-title":"Carbon clearance enhancing factor in serum from levamisole treated mice","volume":"17","author":"Ginckel R.F.","year":"1975","journal-title":"J. reticuloendothel. Soc."},{"key":"e_1_2_1_23_2","first-page":"203","article-title":"Thymosin treatment of children with primary immunodeficiency disease","volume":"10","author":"Wara D.W.","year":"1978","journal-title":"Transplant. Proc."},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1542\/peds.64.5.822","article-title":"Cell\u2010mediated immunity in the newborn: clinical aspects","volume":"64","author":"Wara D.M.","year":"1979","journal-title":"Pediatrics"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197501092920204"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)92261-3"}],"container-title":["Scandinavian Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3083.1982.tb00632.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3083.1982.tb00632.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T21:21:19Z","timestamp":1699651279000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3083.1982.tb00632.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1982,2]]}},"alternative-id":["10.1111\/j.1365-3083.1982.tb00632.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3083.1982.tb00632.x","archive":["Portico"],"relation":{},"ISSN":["0300-9475","1365-3083"],"issn-type":[{"value":"0300-9475","type":"print"},{"value":"1365-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,2]]},"assertion":[{"value":"2006-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}